Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Damian McNamara, MA

    News

    Children and preteen use of melatonin as sleep aid increased

    Author:
    Damian McNamara, MA
    Publish date: November 16, 2023

    Usage of melatonin more than doubled in children and teenagers from 2017 to 2020.

    • Read More

    News

    Jury still out on whether green tea lowers colon cancer risk

    Author:
    Damian McNamara, MA
    Publish date: November 15, 2023

    Combining random trials so far shows no advantage from green tea. But there may still be a benefit.

    • Read More

    News

    Popular liver supplements lack data supporting efficacy, study shows

    Author:
    Damian McNamara, MA
    Publish date: November 6, 2023

    “But our research revealed that strong scientific evidence supporting the efficacy of any of these supplements is currently lacking.”

    • Read More

    News

    Dupilumab promising for children aged 1-11 with EoE

    Author:
    Damian McNamara, MA
    Publish date: October 30, 2023

    Dupilumab was recently approved for adult EOE. It’s been shown to have a good safety profile in adults.

    • Read More

    News

    SGLT2 inhibitors in type 2 diabetes linked to lower risk of developing GI cancers

    Author:
    Damian McNamara, MA
    Publish date: October 30, 2023

    The study is notable for including people with ulcerative colitis and Crohn’s disease and for evaluating every GI cancer.

    • Read More

    News

    IBD biologics, other therapies cleared of causing major adverse cardiovascular events

    Author:
    Damian McNamara, MA
    Publish date: October 27, 2023

    Biologics infliximab, adalimumab, golimumab, certolizumab, vedolizumab, natalizumab, and ustekinumab not only did not increase risk, but they...

    • Read More

    News

    Two multitarget stool tests show promise for CRC screening: Studies

    Author:
    Damian McNamara, MA
    Publish date: October 27, 2023

    "This is the first large study to include the 45- to 49-year-old population, for whom screening is now recommended."

    • Read More

    News

    GLP-1 agonists linked to higher risk for rare but serious GI complications

    Author:
    Damian McNamara, MA
    Publish date: October 13, 2023

    Investigators say their findings are not about scaring people off the weight-loss drugs, but instead about increasing awareness that these...

    • Read More

    News

    Five questions for COVID experts: How concerned should we be?

    Author:
    Damian McNamara, MA
    Publish date: August 31, 2023

    “A challenge with COVID-19, all along, has been disparities in access to care, and this will be worse without public support for prevention and...

    • Read More

    News

    It may be time to pay attention to COVID again

    Author:
    Kara Grant
    Damian McNamara, MA
    Publish date: August 11, 2023

    While the numbers are still low, compared with 2022’s summer surge, experts still urge people to stay aware of changes in the virus. “I do not...

    • Read More

    News

    Experts highlight benefits and offer caveats for first postpartum depression pill

    Author:
    Damian McNamara, MA
    Publish date: August 10, 2023

    “A fast-acting pill that can be taken orally could be an ideal option for the 15% to 20% of women who experience postpartum depression.”

    • Read More

    News

    How newly discovered genes might fit into obesity

    Author:
    Damian McNamara, MA
    Publish date: August 9, 2023

    Although the study is not the first to point to specific genes, “we were quite surprised by the proposed function of some of the genes we...

    • Read More

    News

    ChatGPT in medicine: The good, the bad, and the unknown

    Author:
    Damian McNamara, MA
    Publish date: June 20, 2023

    Three-expert panel at DDW suggests clinicians should embrace the technology.

    • Read More

    News

    Etrasimod looks safe for ulcerative colitis out to 2.5 years

    Author:
    Damian McNamara, MA
    Publish date: June 20, 2023

    If approved by the FDA, etrasimod could become the second agent in the S1P class approved for ulcerative colitis in the United States.

    • Read More

    News

    Wildfire smoke and air quality: How long could health effects last?

    Author:
    Damian McNamara, MA
    Publish date: June 9, 2023

    The effects of smoke from wildfires can continue for many years.

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery